Guan, Jun, et al. “Prognostic Value of Low Skeletal Muscle Mass in Hepatocellular Carcinoma Patients Treated With Sorafenib or Lenvatinib: A Meta-Analysis”. EXCLI Journal, vol. 20, Jan. 2021, pp. 1-16, doi:10.17179/excli2020-3111.